TFX Stock: Price, Earnings History and SEC Filings
Teleflex Incorporated (TFX) last traded at $139.77, down 1.15% on the latest session and up 11.8% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $1.76 against an analyst estimate of $1.28, a beat of 37.5%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
TFX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $1.76 | $1.28 | +37.50% |
| Mar 2026 | May 7, 2026 | $1.39 | $1.21 | +14.88% |
| Dec 2025 | Feb 26, 2026 | $1.93 | $3.73 | -48.26% |
| Sep 2025 | Nov 6, 2025 | $3.67 | $3.38 | +8.58% |
TFX beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How TFX reacts to earnings
Across its last 8 earnings releases, TFX moved 9.4% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | Before open | +1.54% |
| 2026-05-07 | Before open | +6.86% |
| 2026-02-26 | Before open | +6.37% |
| 2026-01-08 | Before open | -13.06% |
| 2025-11-06 | Before open | -13.02% |
| 2025-07-31 | Before open | +4.91% |
| 2025-05-01 | Before open | -8.16% |
| 2025-02-27 | Before open | -21.69% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
TFX financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $2.0B | -$906M | – | -45.4% | $-20.25 |
| 2024 | $1.7B | $70M | – | 4.1% | $1.48 |
| 2023 | $1.7B | $356M | – | 20.8% | $7.53 |
| 2022 | $2.8B | $363M | – | 13.0% | $7.68 |
| 2021 | $2.8B | $485M | – | 17.3% | $10.23 |
| 2020 | $2.5B | $335M | – | 13.2% | $7.09 |
| 2019 | $2.6B | $461M | – | 17.8% | $9.80 |
| 2018 | $2.4B | $201M | – | 8.2% | $4.29 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for TFX
- 8-K · Sep 9, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 7, 2026Other events
- 10-Q · Aug 6, 2026
- 8-K · Aug 6, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Aug 3, 2026Acquisition or disposal completed, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Jun 15, 2026Material agreement, New financial obligation, Financial statements and exhibits
- 8-K · Jun 9, 2026Officer or director change
- 8-K · Jun 2, 2026Other events, Financial statements and exhibits
- 8-K · Jun 1, 2026Regulation FD disclosure, Other events, Financial statements and exhibits
- 8-K · May 27, 2026Material agreement, New financial obligation, Financial statements and exhibits
Insider filing activity
TFX insiders filed 1 Form 4 report in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
TFX news
- FDA Device Breakthrough Might Change The Case For Investing In Teleflex Stock (TFX)Oct 28, 2026 · finance.yahoo.com
- Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium ScaffoldOct 22, 2026 · finance.yahoo.com
- Teleflex Announces Third Quarter 2026 Earnings Conference Call InformationOct 22, 2026 · finance.yahoo.com
- U.S. Wireless Cardiac Monitoring Systems Market Size, Share, and Forecast 2026-2033 Featuring Profiles of Philips, iRhythm Technologies, Abbott, Medtronic, Biotronik (Teleflex) and MoreOct 20, 2026 · finance.yahoo.com
- 1 Value Stock with Exciting Potential and 2 Facing ChallengesOct 19, 2026 · finance.yahoo.com
About Teleflex Incorporated
Teleflex Incorporated (TFX) is a US-listed public company on NYSE. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in DE. Its fiscal year ends in December.